Gardner Lewis

Gardner Lewis Asset Management is a privately owned investment management firm based in Chadds Ford, Pennsylvania, that specializes in active portfolio management and event-driven strategies. Founded in 1990, the firm is a prominent institutional investor in the life sciences, biotechnology, and healthcare sectors, often taking concentrated positions in companies with high-conviction catalysts. It is well-known in the biotech community for its research-intensive, bottom-up approach to identifying market inefficiencies and its history of shareholder activism. The firm gained significant industry attention for its lead role in a successful class-action lawsuit against Genzyme Corporation regarding the valuation of Genzyme Biosurgery shares. Gardner Lewis continues to be an active participant in the healthcare investment landscape, managing assets for individuals, institutions, and private funds.